Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. - Wikidata - wikimedia - TriplyDB

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

http://www.wikidata.org/entity/Q35710041

about

Targeted lipidomics - advances in profiling lysophosphocholine and platelet-activating factor second messengers On the future of mass-spectrometry-based lipidomics Behavioural traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanisms.The impact of chronic stress on the rat brain lipidome Arf6 controls retromer traffic and intracellular cholesterol distribution via a phosphoinositide-based mechanism.Lipidomics-Reshaping the Analysis and Perception of Type 2 Diabetes ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice Emerging methodologies to investigate lipid-protein interactions Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry A neurotoxic glycerophosphocholine impacts PtdIns-4, 5-bisphosphate and TORC2 signaling by altering ceramide biosynthesis in yeast Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Endoplasmic reticulum stress mediates amyloid β neurotoxicity via mitochondrial cholesterol trafficking Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits.Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation.Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease.Analysis of lipid experiments (ALEX): a software framework for analysis of high-resolution shotgun lipidomics data.Predicting glycerophosphoinositol identities in lipidomic datasets using VaLID (Visualization and Phospholipid Identification)--an online bioinformatic search engine.α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.Mass Spectrometry-based Lipidomics and Its Application to Biomedical Research Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease Age-dependent biochemical dysfunction in skeletal muscle of triple-transgenic mouse model of Alzheimer`s disease.Analytical characterization of plasma membrane-derived vesicles produced via osmotic and chemical vesiculation.Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.Lipids under stress--a lipidomic approach for the study of mood disorders.Effects of membrane lipids on the activity and processivity of purified γ-secretase Sterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levels Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis.The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome.LIQUID: an-open source software for identifying lipids in LC-MS/MS-based lipidomics data.Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis Improved MALDI imaging MS analysis of phospholipids using graphene oxide as new matrix.Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease.Upregulated function of mitochondria-associated ER membranes in Alzheimer disease

P2860

Q27008183-5301C8ED-B0A7-4883-B1E8-437A027EDEAB Q27012927-62852F61-FDB1-4A3B-9DFF-1A7DA3F81C8C Q27317789-589FBA77-0267-4B34-B7B3-5CDEF5FF43E5 Q27319840-A24AF150-DC53-419A-AC02-D1FA9947C089 Q27343089-2D0809F9-1BE2-4381-991B-6B8B54772FDD Q28073169-5694EB44-EECB-434A-8FF4-E89627ABD3C0 Q28081654-B9F25108-4E1C-400F-AA14-2D1D782342BE Q28273620-E574F8A1-07E5-421F-AB21-BF9600DD801A Q28386247-5853AD89-AE00-499E-9854-E0FD3FB1FD24 Q28391606-67D89A9D-070B-4D55-BD30-03DC03037B28 Q28539054-221117AA-4E63-4D35-8CB8-79A163A71D16 Q28546902-BF900DE9-6D32-4575-995F-20B5E6AF0DE3 Q30451918-36A99E83-3AC4-4194-BED9-C3E1D006BBEF Q33826820-53A4DC53-08B2-4214-BB06-3670D8DDB384 Q33906496-9DA85A5D-D45F-4885-8E98-E59E0BCED8B9 Q34381799-397AFA08-2099-4A20-B6CA-47E18C89AB02 Q34533119-A534D784-501B-485B-8F3F-9150C0558DAF Q34555955-1F5D0474-D7FC-4F46-8884-DEC4EF89DFD8 Q34974262-06076A91-4445-487E-ACD0-2DBCA130860B Q35034769-AB95B5C2-4B02-42BC-947E-81B44844B6EC Q35045437-EBDC53AA-CBBF-43E2-A85B-A523CE3D1C53 Q35139450-98ED6D29-60C6-4A03-9C03-CEBE39DD6182 Q35307748-B63E76B3-DC0F-49F7-96B4-81A1C1635EF2 Q35332947-DD931359-3053-43DD-8B41-A2BF9E25BB17 Q35566575-F35C1311-1436-4B6B-B992-F8CE0945CFE9 Q35596754-BC0BA683-968A-44AD-9046-2421C72A3FA4 Q35602645-879A4C49-A4A7-450D-9A2F-081F7AC9FB5B Q35666915-B00BA3A4-9A25-47D5-9CB3-A353EB46E78E Q35688942-A317FCEC-9F23-4E06-A7C4-115221083178 Q35795291-97021F9B-1DE4-4AFB-9BE1-3CD436BE328D Q35944806-F6DECBCE-DF61-4D9F-A495-2023D7181B65 Q35977501-CFB65AD6-EBB9-4B4F-A374-C22795EAC662 Q36102989-52B1667B-64A6-48CF-8753-9CF0C1BB8F49 Q36209750-1C1247D5-7D71-4621-9090-D40E7FA88CD3 Q36270188-BB9CD9E3-BC1E-434F-A3B0-36A923E81F17 Q36272443-332B7D41-8654-49A0-846C-D6D19024E868 Q36284241-860C5C2D-D2BF-419C-B8FF-3E59F08F0E7D Q36308188-F563E138-B457-4FC9-9610-2A27092D9787 Q36355644-8ACE307B-2C8E-4AE2-8582-7C11258AAA62 Q36382102-36D3912A-8E02-4C83-B752-1A609F15C353

P2860

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

http://www.wikidata.org/entity/Q35710041

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

@ast

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

@en

type

label

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

@ast

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

@en

prefLabel

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

@ast

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease.

@en

P1433

Q35710041-3ED1EA42-6DCF-47C1-A7E4-34D9C5FAEB09

P1476

Q35710041-43FEDDF4-AF94-40DA-86CA-C62D565E0307

P2093

Q35710041-0FC5CEC8-59AA-4C79-9EE6-CA14396FFCFB

Q35710041-2999C01C-AA56-4B65-8680-199590E80733

Q35710041-2AB73F5C-28A3-4983-991B-AD920B61A8F6

Q35710041-5346A93E-9A4D-4149-AD60-78F0DE1F98D8

Q35710041-85933244-F6D1-4E69-8F66-615D79741ABB

Q35710041-AD22334C-0CFA-4EFD-A996-04A2F71EFE52

Q35710041-BC12AED5-2697-4D02-ABBD-EBA8A1CDE6C6

Q35710041-EEAAF000-DAAE-4423-B589-9390911CE257

P2860

Q35710041-08309397-8FA3-48DB-9B09-43E76D4BDE54

Q35710041-0AF3F369-0140-4C39-9E58-7B156C2386DE

Q35710041-0B494111-0503-4403-AB61-56E321EAFAC6

Q35710041-117EA30F-7755-43DE-AE6A-9AD93CBBFAB3

Q35710041-13C71889-C434-424D-8FE4-94AD32B474B9

Q35710041-1A9BE01D-92AD-4284-B20A-A2DB433A8B34

Q35710041-273D533F-3E58-44D7-9C0C-3EEAEBD8919A

Q35710041-2E810040-FD58-4114-91BF-DAE06A2EBB90

Q35710041-3B463FE8-09CF-4165-97B2-1D1FCC0C22EE

Q35710041-3DC892B4-3F5E-4263-8364-F20B139A2E9B

P304

Q35710041-CCE67AE1-14AE-414A-879D-1C5503C5433D

P31

Q35710041-0ED19A8B-A104-4B76-BEAC-ADDCD66D8AA9

P356

Q35710041-D69EB728-4C4B-4D6A-BC18-7C7636EEC95D

P407

Q35710041-E0FE8827-88E0-4679-B1E8-87A0E34ACFA6

P433

Q35710041-78748996-4533-4956-B49F-5783BE71FE22

P478

Q35710041-EC7A9A7A-94DC-46F6-A945-B600970EC5D7

P50

Q35710041-CD944C72-2873-4598-BC6D-0B4844311487

P577

Q35710041-8745142A-ED81-430A-93A1-A06072FCCB75

P698

Q35710041-08D687DE-CD1D-47D1-AB43-C7DCA5981121

P921

Q35710041-777701AC-D094-411A-873F-383EC5188539

P932

Q35710041-E09F0626-34A0-4FCD-BF07-7CF9DFAE8B7B

P356

JBC.M111.274142

P1433

Journal of Biological Chemistry

P1476

Comparative lipidomic analysis of mouse and human brain with Alzheimer disease

@en

P2093

Etty P Cortes

http://www.w3.org/2001/XMLSchema#string

Gilbert Di Paolo

http://www.w3.org/2001/XMLSchema#string

Guanghou Shui

http://www.w3.org/2001/XMLSchema#string

Karen E Duff

http://www.w3.org/2001/XMLSchema#string

Lawrence S Honig

http://www.w3.org/2001/XMLSchema#string

Markus R Wenk

http://www.w3.org/2001/XMLSchema#string

Robin B Chan

http://www.w3.org/2001/XMLSchema#string

Scott A Small

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Diacylglycerols and phosphatidates: which molecular species are intracellular messengers?

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

Lipid pathway alterations in Parkinson's disease primary visual cortex

Subcellular organelle lipidomics in TLR-4-activated macrophages

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

P304

2678-2688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M111.274142

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

287

http://www.w3.org/2001/XMLSchema#string

P50

Tiago Gil Oliveira

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22134919

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3268426

http://www.w3.org/2001/XMLSchema#string